{
    "eid": "2-s2.0-84966393518",
    "title": "Virologic failure is uncommon after treatment initiation during acute HIV infection",
    "cover-date": "2016-07-31",
    "subject-areas": [
        {
            "$": "Immunology",
            "@code": "2403"
        },
        {
            "$": "Immunology and Allergy",
            "@code": "2723"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        }
    ],
    "keywords": [
        "acute HIV",
        "highly active antiretroviral therapy",
        "HIV",
        "viral load",
        "virologic failure"
    ],
    "authors": [
        "Trevor A. Crowell"
    ],
    "citedby-count": 25,
    "ref-count": 25,
    "ref-list": [
        "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for A Public Health Approach",
        "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents",
        "European AIDS Clinical Society",
        "Antiretroviral treatment of adult HIV infection: 2014 Recommendations of the International Antiviral Society-USA panel",
        "Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts",
        "Impact of multi-targeted antiretroviral treatment on gut t cell depletion and hiv reservoir seeding during acute hiv infection",
        "Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells",
        "Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size",
        "J Virus Erad",
        "Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation",
        "Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy",
        "Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy",
        "Viral replication under combination antiretroviral therapy: A comparison of four different regimens",
        "Duration of viral suppression in patients on stable therapy for HIV-1 infection is predicted by plasma HIV RNA level after 1 month of treatment",
        "Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection",
        null,
        "Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection",
        "Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen",
        "Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS",
        "Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection",
        "Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-na\u00efve volunteers infected with HIV-1: A Randomized, controlled equivalence trial",
        "Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1",
        "Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings",
        "Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): A randomised, open-label, phase 3 trial",
        "A randomized open-label study of 3-versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rockville",
            "affilname": "HJF",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Silver Spring",
            "affilname": "Walter Reed Army Institute of Research",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Pensacola",
            "affilname": "SEARCH",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Silver Spring",
            "affilname": "US Military HIV Research Program",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "San Francisco",
            "affilname": "AFRIMS",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}